Assessing diabetes risk

Know more sooner—identify prediabetes and high-risk patients

With our risk panels, you’ll be able to identify more patients with insulin resistance (IR) or prediabetes who are at risk of developing diabetes. Recognizing risk, including hidden risk, earlier, means you can do more sooner to stop or delay the progression to diabetes before it becomes more complex to manage.

Make a difference with our diabetes laboratory test features

Our diabetes risk tests offer key advantages, so you can make a difference when it matters most:

  • Simple, accurate identification of insulin resistance—enables even earlier intervention for insulin-resistant patients who haven’t yet experienced loss of β-cell function 1,2
  • Combined glucose and HbA1c— testing for both can provide greater accuracy in identifying prediabetes than testing for either marker alone3-6
  • Diabetes Risk Score—a powerful tool that measures risk of developing diabetes over the next 8 years7

  • Graphical report format—helps you clearly communicate risk to your patients

Learn more about the tests we offer for assessing diabetes risk

We offer a variety of diabetes risk panels to meet the needs of your particular patients and your practice. Choose from the Cardio IQ® Insulin Resistance Panel with Score, the Diabetes Risk Panel with Score, or opt for a panel that also offers insight into cardiovascular risk.

Learn about making a differential diagnosis of diabetes

Let us help you know what’s ahead

Contact a Quest Diagnostics sales representative to learn more
1.866.MYQUEST (1.866.697.8378)

Want to learn more about ADA guidelines-based testing?
Watch the webinar

View sample report

1 American Diabetes Association, National Institute of Diabetes, Digestive and Kidney Disorders.
   The prevention or delay of type 2 diabetes. Diabetes Care. 2002;25:742-749.

2 Genuth S, Kahn R. A step backward—or is it forward? Diabetes Care. 2008;31:1093-1096.

3 Schöttker B, Raum E, Rothenbacher D, et al. Prognostic value of haemoglobin A1c and fasting
   plasma glucose for incident diabetes and implications for screening. Eur J Epidemiol. 2011;26:779-787.

4 Sato KK, Hayashi T, Harita N, et al. Combined measurement of fasting plasma glucose and A1c is effective
   for the prediction of type 2 diabetes. The Kansai Healthcare Study. Diabetes Care. 2009;32:644-646.

5 Soulimane S, Simon D, Shaw J, et al. HbA1c, fasting plasma glucose and the prediction of
   diabetes: Inter99, AusDiab and D.E.S.I.R. Diab Res Clin Pract. 2012;96:392-399.

6 Wang W, Lee ET, Howard BV, et al. Fasting plasma glucose and hemoglobin A1c in identifying
   and predicting diabetes. Diabetes Care. 2011;34:363-368.

7 Leong A, Daya N, Porneala B, et al. Prediction of type 2 diabetes by hemoglobin A1c in two
   community-based cohorts. Diabetes Care. 2018;41(1):60-68.